CAS: 141388-76-3; (R)-7-(3-Aminoazepan-1-yl)-8-Chloro-1-Cyclopropyl-6-Fluoro-4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid

该化合物是一种主要用于治疗细菌结膜炎的合成五氟丙酮抗生素,其特点是其高溶性,有助于将其配制成一种眼科疗法,其特点是,它具有广泛频谱抗菌性,特别是抗抗菌性抗菌活动,特别是抗抗格抗菌活动,包括耐其他抗生素的菌株;Besifloxin的化学结构具有氟原子双环核特征,可增强它的威力和活动范围;它具有高溶性,其特点是水中溶性很强,有助于将其配制成一种局部应用的眼科治疗方法;Besifloxinacin通过抑制细菌DNA甘蓝和对细菌DNA复制和修复至关重要的异构体IV酶,这种行动机制导致细菌细胞分裂的中断,最终导致细胞死亡;该物质一般都受到良好的调试,其副作用较低,成为治疗眼感染的首选;同任何抗生一样,适当使用该物质对于尽量减少抗生性风险至关重要.

结构式图片

合成工艺路线路线简述

    📜盐酸贝西沙星置于sodium Hydroxide体系中,用 水 用作溶剂,化学反应 2.5H,以87%的收率获得贝西沙星
    参考文献: Acid Salts Of Fluoroquinolone Carboxylic Acid Based Compositions And Methods Of Making And Using The Same[fr] Sels D'Acide De Compositions à Base D'Acide Fluoroquinolone Carboxylique Et Procédés De Fabrication Et D'Utilisation Associés
    标题: Acid Salts Of Fluoroquinolone Carboxylic Acid Based Compositions And Methods Of Making And Using The Same[fr] Sels D'Acide De Compositions à Base D'Acide Fluoroquinolone Carboxylique Et Procédés De Fabrication Et D'Utilisation Associés
    摘要:本公开涉及制药和化学科学领域.本公开通常涉及治疗剂的合成,制备该类剂的过程,包含该类治疗剂的组合物以及它们的用途.具体而言,该公开涉及药用重要的氟喹诺酮羧酸盐基化学分子[式(i)的化合物],制备这些分子的方法,其组合物,以及将这类分子用作治疗剂的用途.所述的氟喹诺酮羧酸盐基化学分子的酸盐在治疗感染方面具有用途,如耳部感染,中耳炎,包括急性中耳炎,复发性中耳炎,伴有渗出物的中耳炎,慢性中耳炎,慢性化脓性中耳炎,外耳炎(包括急性外耳炎,慢性外耳炎),内耳炎以及其组合.

    海关参考信息

    专利信息


    专利号:US-7632944-B2
    优先权日:2007-01-24
    标题 :Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
    发明人:HARMS ARTHUR E
    权利人:BAUSCH & LOMB
    摘要:A process of preparing a quinolone carboxylic acid or its derivatives having Formula I, Ia, or IV, as shown herein, comprises using a starting quinolone that already has one or more desired substituents at one or more particular positions on the quinolone ring and preserving the orientation of such substituents throughout the synthesis. The present process comprises fewer steps than prior-art processes. The present process also can include a simple separation of a desired enantiomer of the quinolone carboxylic acid or its derivatives from the enantiomeric mixture. Pharmaceutical compositions comprising fluoroquinolones prepared by the present process can be used effectively against a variety of microbial pathogens.

    专利号:US-8227597-B2
    优先权日:2006-10-06
    标题 :Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
    发明人:HARMS ARTHUR E
    权利人:HARMS ARTHUR E; BAUSCH & LOMB
    摘要:A process of preparing a quinolone carboxylic acid or its derivatives having Formula I, Ia, or IV, as shown herein, comprises using a starting quinolone that already has one or more desired substituents at one or more particular positions on the quinolone ring and preserving the orientation of such substituents throughout the synthesis. The present process comprises fewer steps than prior-art processes. The present process also can include a simple separation of a desired enantiomer of the quinolone carboxylic acid or its derivatives from the enantiomeric mixture. Pharmaceutical compositions comprising fluoroquinolones prepared by the present process can be used effectively against a variety of microbial pathogens.

    专利号:US-8252783-B2
    优先权日:2007-01-24
    标 题:Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
    发明人:HARMS ARTHUR E; ARUL RAMAKRISHNAN; SONI ANIL K
    权利人:HARMS ARTHUR E; ARUL RAMAKRISHNAN; SONI ANIL K; BAUSCH & LOMB
    摘要:A process of preparing a quinolone carboxylic acid or its derivatives having Formula I, Ia, Ib, or IV, as shown herein, comprises using a starting quinolone that already has one or more desired substituents at one or more particular positions on the quinolone ring and preserving the orientation of such substituents throughout the synthesis. The present process comprises fewer steps than prior-art processes. The present process also can include a simple separation of a desired enantiomer of the quinolone carboxylic acid or its derivatives from the enantiomeric mixture. Pharmaceutical compositions comprising fluoroquinolones prepared by the present process can be used effectively against a variety of microbial pathogens.

    专利号:US-9295731-B2
    优先权日:2013-04-01
    标题 :Cleavable drug conjugates, compositions thereof and methods of use
    发明人:NGUYEN MARK QUANG
    权利人:NGUYEN MARK QUANG
    摘要:Base-labile crosslinkers, base-labile conjugates comprising such crosslinkers, methods of their synthesis and use are disclosed.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:Synthesis And Evaluation Of Dual-Action Kanglemycin-Fluoroquinolone Hybrid Antibiotics
    作者:James Peek,Bimal Koirala,Sean F. Brady |发布日期:2022.2
    摘要:And A Collection Of Fluoroquinolones. Kang A Is A Natural Product Antibiotic Which Contains A Novel Dimethyl Succinic Acid Moiety That Offers A New Attachment Point For The Synthesis Of Hybrid Antibiotics. We Compare The Activity Of The Kang A Hybrids Generated Via The Acid Attachment Point To A Series Of Hybrids Linked At The Compound'S Naphthoquinone Ring System. Several Hybrids Exhibit Activity Against

    合成参考文献


    参考文献:10.1016/j.jcrs.2010.12.046
    摘要:Donnenfeld ED, Comstock TL, Proksch JW. Human aqueous humor concentrations of besifloxacin, moxifloxacin, and gatifloxacin after topical ocular application. J Cataract Refract Surg. 2011 Jun;37(6):1082–9. doi: 10.1016/j.jcrs.2010.12.046.
    参考文献:10.2165/11589020-000000000-00000
    摘要:Benitez-Del-Castillo J, Verboven Y, Stroman D, Kodjikian L. The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis. Clin Drug Investig. 2011;31(8):543–57. doi: 10.2165/11589020-000000000-00000.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知